Opioids are integral to most post-surgical pain management strategies. However, post-operative patients at risk for obstructive or central sleep apnea are particularly vulnerable to undetected respiratory depression.
Analysis of site claims reviews suggest that improved surveillance techniques could prevent most opioid-induced respiratory depression (OIRD) events. Continuous clinical surveillance is a powerful tool for prediction, mitigates alarm fatigue and facilitates the distribution of real-time data to centralized dashboards or mobile devices.
As such, continuous clinical surveillance has been recommended as a best practice by prominent healthcare advocates and governing agencies.
The purpose of this white paper is to:
- Define the inherent risks associated with undetected OIRD in patients with obstructive or central sleep apnea
- Identify the short-comings of current surveillance tactics
- Describe the key elements of continuous clinical surveillance
- Demonstrate the efficacy of continuous clinical surveillance